You have 9 free searches left this month | for more free features.

Deferiprone

Showing 1 - 25 of 74

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pantothenate Kinase-Associated Neurodegeneration Trial (Deferiprone)

No longer available
  • Pantothenate Kinase-Associated Neurodegeneration
  • Deferiprone
  • (no location specified)
Nov 9, 2022

Acute Myocardial Infarction Type 1 Trial in Indianapolis (Deferiprone Tablets, Placebo)

Recruiting
  • Acute Myocardial Infarction Type 1
  • Deferiprone Tablets
  • Placebo
  • Indianapolis, Indiana
    Krannert Cardiovascular Research Center
Dec 14, 2022

SAH, Dementia Trial in Iowa City (Deferiprone pill, , Montreal Cognitive Assessment)

Recruiting
  • SAH
  • Dementia
  • Deferiprone pill
  • +2 more
  • Iowa City, Iowa
    Univesity of Iowa Hospital and Clinics
Mar 7, 2022

Aceruloplasminemia Trial in Fuzhou (Deferiprone treated)

Recruiting
  • Aceruloplasminemia
  • Deferiprone treated
  • Fuzhou, Fujian, China
    Department of Neurology , First Affiliated Hospital Fujian Medic
Nov 21, 2021

Mild Cognitive Impairment, Prodromal Alzheimer's Disease, Mild Alzheimer's Disease Trial in Australia (Deferiprone 600mg delayed

Active, not recruiting
  • Mild Cognitive Impairment
  • +2 more
  • Deferiprone 600mg delayed release tablets
  • Placebo Oral Tablet
  • Macquarie Park, New South Wales, Australia
  • +7 more
Mar 8, 2022

Amyotrophic Lateral Sclerosis Trial in France (Deferiprone, Placebo Oral Tablet)

Active, not recruiting
  • Amyotrophic Lateral Sclerosis
  • Deferiprone
  • Placebo Oral Tablet
  • Angers, France
  • +14 more
Nov 4, 2022

Stroke Trial in Bordeaux, Lille, Montpellier (Magnetic Resonance Imaging (MRI), Deferiprone treatment)

Recruiting
  • Stroke
  • Magnetic Resonance Imaging (MRI)
  • Deferiprone treatment
  • Bordeaux, France
  • +2 more
Jun 9, 2022

Iron Overload Due to Repeated Red Blood Cell Transfusions Trial in Worldwide (Deferiprone DR tablets 1000 mg (Low dosage),

Completed
  • Iron Overload Due to Repeated Red Blood Cell Transfusions
  • Deferiprone DR tablets 1000 mg (Low dosage)
  • Deferiprone DR tablets 1000 mg (High dosage)
  • Chicago, Illinois
  • +4 more
Jun 17, 2021

Beta Thalassemia Major Anemia, Iron Overload Trial in Cairo, Jakarta (Deferiprone oral solution, Placebo)

Completed
  • Beta Thalassemia Major Anemia
  • Iron Overload
  • Deferiprone oral solution
  • Placebo
  • Cairo, Egypt
  • +3 more
Feb 9, 2021

Chronic Iron Overload Trial in Worldwide (Deferiprone, Deferasirox)

Completed
  • Chronic Iron Overload
  • Lushnjë, Albania
  • +21 more
Apr 8, 2021

Pantothenate Kinase-Associated Neurodegeneration Trial in Worldwide (Deferiprone oral solution)

Completed
  • Pantothenate Kinase-Associated Neurodegeneration
  • Deferiprone oral solution
  • Oakland, California
  • +3 more
Aug 12, 2020

Parkinson's Disease Trial in London (Deferiprone 20mg, Placebo, Deferiprone 30mg)

Completed
  • Parkinson's Disease
  • Deferiprone 20mg
  • +2 more
  • London, United Kingdom
    Centre for Neuroscience, Imperial College London
Jun 3, 2020

Acute Kidney Injury Trial (deferiprone, Placebo)

Withdrawn
  • Acute Kidney Injury
  • deferiprone
  • Placebo
  • (no location specified)
Aug 20, 2020

Iron Overload, Sickle Cell Disease, Other Anemias Trial in Worldwide (Deferiprone, Deferoxamine)

Terminated
  • Iron Overload
  • +2 more
  • Oakland, California
  • +32 more
Jul 16, 2021

Parkinson Disease Trial in Worldwide (Deferiprone, Placebo)

Active, not recruiting
  • Parkinson Disease
  • Deferiprone
  • Placebo
  • Innsbruck, Austria
  • +24 more
Mar 9, 2021

Parkinson's Disease, Amyotrophic Lateral Sclerosis, Oxidative Stress Trial in Lille (deferiprone, )

Completed
  • Parkinson's Disease
  • +3 more
  • deferiprone
  • placebo
  • Lille, France
    Hôpital Roger Salengro, CHRU de Lille
Mar 25, 2020

Deferiprone (Ferriprox®) in Treatment of Superficial Siderosis

Completed
  • Superficial Siderosis
    • Baltimore, Maryland
      Johns Hopkins University
    Aug 26, 2019

    Parkinson's Disease Trial in Worldwide (Deferiprone, Placebo)

    Completed
    • Parkinson's Disease
    • Deferiprone
    • Placebo
    • Toronto, Ontario, Canada
    • +19 more
    Nov 14, 2019

    Thalassemia Major Trial (n-acetylcystine)

    Not yet recruiting
    • Thalassemia Major
    • (no location specified)
    Mar 9, 2023

    Letrozole, Infertility, Female Trial in Shanghai (Letrozole)

    Recruiting
    • Letrozole
    • Infertility, Female
    • Shanghai, China
      Yu Xiao
    Aug 16, 2023

    Pantothenate Kinase-Associated Neurodegeneration Trial in Worldwide (Deferiprone oral solution, Placebo)

    Completed
    • Pantothenate Kinase-Associated Neurodegeneration
    • Deferiprone oral solution
    • Placebo
    • Oakland, California
    • +3 more
    Jun 27, 2019

    Thalassemia Major With Severe Transfusional Iron Overload Trial in Chicago, Philadelphia (Deferasirox and deferiprone)

    Completed
    • Thalassemia Major With Severe Transfusional Iron Overload
    • Deferasirox and deferiprone
    • Chicago, Illinois
    • +1 more
    Feb 13, 2019

    Thalassemia, Beta Trial in Karachi (Hydroxyurea and Thalidomide)

    Completed
    • Thalassemia, Beta
    • Hydroxyurea and Thalidomide
    • Karachi, Sindh, Pakistan
      Children's Hospital Karachi
    Nov 23, 2023

    Myelodysplastic Syndrome With Low-grade Lesions, Iron Overload Due to Repeated Red Blood Cell Transfusions Trial in Tel Hashomer

    Completed
    • Myelodysplastic Syndrome With Low-grade Lesions
    • Iron Overload Due to Repeated Red Blood Cell Transfusions
    • Deferiprone
    • Tel Hashomer, Israel
      Chim Sheba Medical Center
    Oct 30, 2018

    Iron Overload, Sickle Cell Disease, Other Anemias Trial in Worldwide (Deferiprone)

    Unknown status
    • Iron Overload
    • +2 more
    • Deferiprone
    • Oakland, California
    • +12 more
    Jan 10, 2019